Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease

Table 2

Laboratory data on additional treatment.

		Group A ()	Group B ()	95% CI	value
WBC (10^9/L)	Before therapy			0.50-3.98	0.292
	After therapy			0.71-1.57	0.087
	△WBC			0.50-3.94	0.247
N (%)	Before therapy			0.06-3.58	0.053
	After therapy			0.06-3.99	0.127
	△neutrophils			0.27-0.84	0.048
CRP (mg/L)	Before therapy			0.19-7.25	0.652
	After therapy			0.28-6.99	0.725
	△CRP			0.10-0.52	0.039
HGB (g/L)	Before therapy			0.27-1.57	0.125
	After therapy			0.28-1.57	0.265
	△HGB			0.25-1.32	0.114
PLT (10^9/L)	Before therapy			0.6-3.72	0.458
	After therapy			0.52-1.20	0.850
	△PLT			0.13-0.57	0.027
Albumin (g/L)	Before therapy			0.51-1.19	0.232
	After therapy			0.52-1.20	0.335
	△albumin			0.19-0.80	0.110
Sodium (mmol/L)	Before therapy			0.30-7.25	0.630
	After therapy			0.28-6.99	0.095
	△sodium			0.27-0.83	0.043

Data are expressed as the . WBC = white blood cells; HGB = hemoglobin; CRP = C-reactive protein; PLT = platelets; Group A: IVIG retreatment group; Group B: MPT group. Before therapy: values 1 d before the 2nd treatment. After therapy: values 7 d after the 2nd treatment. △: difference in laboratory data were calculated using the equation values 7 d after the 2nd 1 d before the 2nd treatment.